Chest
-
Pleural Case Report PostersSESSION TYPE: Case Report PosterPRESENTED ON: Sunday, March 23, 2014 at 01:15 PM - 02:15 PMINTRODUCTION: The controlled ovarian stimulation (COS) may cause Ovarian Hyperstimulation Syndrome (OHS). The severe OHS is characterized by ascites and pleural effusion, due to movement of fluid in the extravascular space. A case of a woman who developed a clinical picture similar to severe OHS after COS and total hysterectomy is presenting. ⋯ The following authors have nothing to disclose: Eleftheria Haini, Andreas Afthinos, Eleftherios Markatis, Dimitra Haini, Linos Tsilias, Kostas Pagratis, Ilias Papanikolaou, Kyriakos HainisNo Product/Research Disclosure Information.
-
ILD Case Report Posters ISESSION TYPE: Case Report PosterPRESENTED ON: Sunday, March 23, 2014 at 01:15 PM - 02:15 PMINTRODUCTION: Sarcoidosis, a multisystem granulomatous disorder, has variable clinical presentations. Though most of the diagnosed cases are asymptomatic or present with pulmonary, ocular, cardiac or neurologic manifestations, there have been fewer than dozen cases reported, initially presenting with lower leg edema. We report the case of a patient presenting with bilateral leg edema and generalized lymphadenopathy without any pulmonary symptoms. Lymph node biopsy revealed non-caseating granulomas consistent with sarcoidosis. ⋯ The following authors have nothing to disclose: Viral Patel, Abhay Vakil, Punit Jariwala, Kelly Cervellione, Artur ShalonovNo Product/Research Disclosure Information.
-
OSA PostersSESSION TYPE: Poster PresentationsPRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PMPURPOSE: Obstructive Sleep Apnea (OSA) represents a perioperative risk. Continuous positive airway pressure (CPAP) therapy has demonstrated its ability to reduce this risk. However, many patients don't adhere to this treatment. Our study was designed to identify patients with poor adherence to CPAP therapy. ⋯ The following authors have nothing to disclose: Eric Deflandre, Stephanie Degey, Vincent Bonhomme, Anne-Francoise Donneau, Robert Poirrier, Jean-Francois Brichant, Pol HansNo Product/Research Disclosure Information.
-
Cancer Case Report Posters ISESSION TYPE: Case Report PosterPRESENTED ON: Sunday, March 23, 2014 at 01:15 PM - 02:15 PMINTRODUCTION: Bronchioloalveolar carcinoma is a subtype of adenocarcinoma characterized by peripheral location, good histological differentiation, lepidic growth pattern and potential for aerogenous and lymphatic dissemination. We report the case of a patient with a diffuse variant of bronchioloalveolar carcinoma (BAC) which is confused with interstitial conditions such as hypersensitivity pneumonitis, atypical pneumonia, idiopathic interstitial pneumonitis or respiratory bronchiolitis. ⋯ The variable characteristics of bronchioloalveolar carcinoma and its diffuse presentation make confusion with a number of diseases probable, including interstitial lung diseases. Therefore we consider it advisable to obtain histopathological confirmation in those patients with atypical presentations or slow progression, and to consider bronchioloalveolar carcinoma as a diagnostic alternativeReference #1: Howar J West. Bronchioloalveolar carcinoma, including adenocarcinoma in situ. Wolters Kluwer Health. Up to date Review Juny 2013Reference #2: American thoracic society/european respiratory society international multidiciplinary classification of lung adenocarcinoma. Jthorac Oncol 2011; 6:244Reference #3: H. Bronchioloalveolar carcinoma masquerading as pneumonia. Respir Care 2004; 49:1349DISCLOSURE: The following authors have nothing to disclose: Julián Ceballos Gutiérrez, Juan Cruz Rueda, Cintia Merinas López, Ana Dolores Romero OrtizNo Product/Research Disclosure Information.
-
ILD Case Report Posters ISESSION TYPE: Case Report PosterPRESENTED ON: Sunday, March 23, 2014 at 01:15 PM - 02:15 PMINTRODUCTION: Granulomatous interstitial lung disease (GL-ILD) develops in a subset of patients with common variable immunodeficiency (CVID) and is commonly confused with sarcoidosis. Little is known about the treatment options and their efficacies in GL-ILD. It is also unclear whether all patients with GL-ILD in the setting of CVID need treatment. ⋯ The following authors have nothing to disclose: Avni Joshi, Paolo Pianosi, Shakila Khan, Michael Ishitani, Thomas Boyce, David ViswanathaNo Product/Research Disclosure Information.